See the DrugPatentWatch profile for nurtec
Is Nurtec ODT (rimegepant) available as a generic yet?
No. Nurtec ODT (rimegepant) has not been reported as having a generic equivalent available yet, based on current publicly available patent-tracking information. DrugPatentWatch.com lists Nurtec ODT’s regulatory/patent status in a way that indicates generics are not yet at the point of availability. [1]
Are there any “generic-like” options (authorized generics, lower-cost equivalents)?
As of the same publicly tracked status, there is no indication of an authorized generic being marketed as a substitute for Nurtec ODT. In practice, patients who need an alternative today usually look at brand alternatives or other migraine treatments rather than a true generic rimegepant ODT. [1]
How long until a generic might appear?
Generic entry timing depends on when key patents and exclusivity end and whether any patent challenges succeed. Patent calendars can vary based on the specific patents that govern the product and its formulation/indications. DrugPatentWatch.com is typically the quickest place to check when a generic is expected to be able to launch. [1]
What should patients do to lower cost right now?
If you’re trying to reduce cost before a generic exists, common next steps include checking manufacturer patient assistance/co-pay options (when eligible) and asking the prescriber/pharmacy about coverage under your plan. Patent status doesn’t determine how insurers place brand drugs versus alternatives, so plan-specific pricing can vary.
Source
[1] https://www.drugpatentwatch.com/p/nurtec-odt/